Lung Transplant Candidates: Effects of Aerobic vs. HIIT Training on ICF Assessments
Comparison of the Effects of Continuous Aerobic Exercise Training and High-Intensity Interval Exercise Training on ICF-Based Assessments in Lung Transplant Candidates
1 other identifier
interventional
34
1 country
1
Brief Summary
Lung transplantation is a crucial surgical intervention aimed at increasing survival rates in patients with end-stage lung diseases such as chronic obstructive pulmonary disease (COPD), cystic fibrosis, idiopathic pulmonary fibrosis, and pulmonary hypertension. One of the most important determinants of health outcomes before and after lung transplantation is exercise capacity. An increase in the 6-minute walking distance (6MWD), which serves as a measure of functional exercise capacity, is associated with lower mortality rates in both pre- and post-transplantation settings. Therefore, effective rehabilitation programs are needed to enhance the exercise capacities of lung transplant candidates. Pulmonary rehabilitation (PR) is a comprehensive program designed specifically for individuals with chronic respiratory diseases. PR aims to improve patients\' physical and psychological conditions through detailed assessments and personalized treatment plans. It can play a role in enhancing the preoperative exercise capacities of lung transplant candidates and improving their chances of successful health outcomes. However, lung transplant candidates often have more advanced lung disease and face greater challenges compared to typical patients undergoing PR, making the expected benefits more complex to achieve. The primary aim of this study is to investigate the effects of high-intensity interval training (HIIT) in lung transplant candidates with interstitial lung disease (ILD). The first objective is to compare the physiological responses and effectiveness of HIIT and moderate-intensity continuous training (MICT) within the same exercise volume. The secondary aim is to evaluate the impact of HIIT on body structure and function, activity, and participation levels using ICF-based assessments.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2024
CompletedFirst Submitted
Initial submission to the registry
November 21, 2024
CompletedFirst Posted
Study publicly available on registry
July 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2026
CompletedJuly 15, 2025
July 1, 2025
1.2 years
November 21, 2024
July 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Cardiopulmonary exercise capacity
Peak Work Rate (PWR) PWR is determined through a symptom-limited incremental bicycle ergometer test. Patients pedal at 10 W, increasing by 10 W each minute until fatigue or a workload of 50 W is reached, or a fatigue level of 9 on the modified Borg scale. Workload and heart rate are monitored, with maximum workload (Wpeak) and heart rate recorded at the end.
through study completion, an average of 1 year
Submaximal exercise capacity
-Minute Walk Test (6MWT) The 6MWT assesses exercise capacity in a 30-meter corridor by measuring the distance walked. It evaluates oxygen saturation, heart rate, and dyspnea using the Borg scale before and after the test. Participants walk at their own pace and can pause or use oxygen as needed.
through study completion, an average of 1 year
Secondary Outcomes (9)
Forced Expiratory Volume in 1 Second (FEV1) Measured by Spirometry (Liters)
through study completion, an average of 1 year
Fragility
through study completion, an average of 1 year
Life Quality
through study completion, an average of 1 year
Kinesiophobia
through study completion, an average of 1 year
Muscle strength
through study completion, an average of 1 year
- +4 more secondary outcomes
Study Arms (2)
LV-HIIT (Low-Volume High-Intensity Interval Training)
EXPERIMENTALThe first randomly assigned group will perform 30 seconds of high-intensity exercise at 85-100% of their maximum workload, followed by 30 seconds of exercise at 40% of their maximum workload. This 30-second high-intensity exercise followed by 30 seconds of low-intensity exercise will be referred to as one cycle. A total of 20 cycles will be completed. Additionally, 2 minutes of low-intensity warm-up and cool-down exercises will be performed.
MICT (Moderate-Intensity Continuous Training)
ACTIVE COMPARATORThe second group determined as a result of randomization will exercise for 20-30 minutes at 60-80% of maximum workload. Exercise volume (duration × %Wpeak) matched between groups.
Interventions
30-sec intervals at 85-100% peak workload, 30-sec rest at 40%, total 20-30 min.
Continuous cycling at 60-80% peak workload for 20-30 min.
Electronically Ergometer cycle custo ec5000, CustoMed used for all exercise sessions. Calibrated before each trial.
Eligibility Criteria
You may qualify if:
- Being diagnosed with interstitial lung disease and being followed up at the Ankara City Hospital Chest Diseases Clinic,
- Being 18 years of age or older,
- Patients who are being followed up with a diagnosis of ILD according to the ATS/ERS 2022 international ILD guideline,
- Being on the lung transplant waiting list according to the International Society for Heart and Lung Transplantation and are being evaluated for listing and are being followed up by the chest diseases department (25-28),
- Being willing to participate in the exercise program regularly and volunteering to participate in the study,
- Patients who have dyspnea levels of 2 and above according to the Modified Medical Research Council dyspnea scale and are able to ambulate,
- Patients who receive long-term oxygen support will be included.
You may not qualify if:
- Patients with a history of exertional syncope,
- Patients in acute exacerbation,
- Patients with sarcoidosis,
- Patients with serious comorbidities that may limit exercise (e.g. musculoskeletal, neurological or cardiovascular problems) will not be included.
- Patients with an aortic aneurysm greater than 5.5 cm,
- Patients with cardiovascular impediments to exercise during cardiological evaluations prior to pulmonary rehabilitation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ankara Bilkent City Hospital
Ankara, Ankara, 06000, Turkey (Türkiye)
Related Publications (1)
Hume E, Ward L, Wilkinson M, Manifield J, Clark S, Vogiatzis I. Exercise training for lung transplant candidates and recipients: a systematic review. Eur Respir Rev. 2020 Oct 28;29(158):200053. doi: 10.1183/16000617.0053-2020. Print 2020 Dec 31.
PMID: 33115788BACKGROUND
Study Officials
- STUDY CHAIR
Hatice K Kılıc, Prof. Dr.
Ankara City Hospital Bilkent
- STUDY DIRECTOR
Ebru CK Calık Kutukcu, Prof. Dr.
Hacettepe University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 21, 2024
First Posted
July 15, 2025
Study Start
November 1, 2024
Primary Completion
January 1, 2026
Study Completion
January 1, 2026
Last Updated
July 15, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share